Appendix 3Y - Silviu Itescu

Skip to main navigation Home Company Overview Board of Directors Management Team Corporate Governance Contact Us Product Candidates Product Candidates Overview Cardiovascular Diseases Spine Orthopedic Disorders Oncology & Hematology Immune-Mediated & Inflammatory Conditions Clinical Trials Science Mesenchymal Lineage Cells Mechanisms of Action Manufacturing Intellectual Property Scientific Publications Partnerships Overview Investors & Media Investor Relations At A Glance Overview Corporate Governance Board of Directors Management Team Company Announcements ASX Announcements Share Price & Tools Stock Quote & Chart Historical Lookup Calculator Events & Presentations Events Presentations Financial Information SEC Filings Annual Reports Financial Reports Analyst Coverage Earnings Estimates Financial Fundamentals Shareholder Services ADR Trading FAQs Information Request E-mail Alerts Careers Current Opportunities Home Contact Us Company Overview Board of Directors Management Team Corporate Governance Contact Us Product Candidates Product Candidates Overview Cardiovascular Diseases Spine Orthopedic Disorders Oncology & Hematology Immune-Mediated & Inflammatory Conditions Clinical Trials Science Mesenchymal Lineage Cells Mechanisms of Action Manufacturing Intellectual Property Scientific Publications Partnerships Overview Investors & Media Header investor menu At a Glance Company Announcements Share Price & Tools Events and Presentations Financial Information Shareholder Services Careers Current Opportunities News Release Appendix 3Y - Silviu Itescu July 21, 2026 at 9:47 AM AEST 031c5a0b-cac3-440f-9b3a-efc28542a016.pdf 832.2 KB Investor Relations At A Glance Overview Corporate Governance Board of Directors Management Team Company Announcements ASX Announcements Share Price & Tools Stock Quote & Chart Historical Lookup Calculator Events & Presentations Events Presentations Financial Information SEC Filings Annual Reports Financial Reports Analyst Coverage Earnings Estimates Financial Fundamentals Shareholder Services ADR Trading FAQs Information Request E-mail Alerts Tools Print Page RSS Feeds Email Alerts Share Price : as of Jul 30, 2026 Company Overview Board of Directors Management Team Corporate Governance Contact Us Product Candidates Product Candidates Overview Cardiovascular Diseases Spine Orthopedic Disorders Oncology & Hematology Immune-Mediated & Inflammatory Conditions Clinical Trials Science Mesenchymal Lineage Cells Mechanisms of Action Manufacturing Intellectual Property Scientific Publications Partnerships Overview Careers Current Opportunities Investors & Media Header investor menu At a Glance Company Announcements Share Price & Tools Events and Presentations Financial Information Shareholder Services Copyright © 2026 Mesoblast Ltd Disclaimer Privacy Policy Search